InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
2
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by McEachin Thomas, Director. Director active across 5 companies, notably Pediatrix Medical Group, Inc.. Cumulatively, 18 disclosures have been logged. Breakdown: 2 buys · 0 sell. Total volume traded: €35k. History available since 7 May 2021. The latest transaction was filed on 13 May 2026 (Don). Regulator: SEC (Form 4). All data is free.
Declarations18 total
11,427 shares0Common StockSEC:0001193125-26-224279
11,427 shares0Common StockSEC:0001193125-26-224279:0
11,427 shares0Common StockSEC:0000950170-25-069433:0
1,072 shares0Common Shares of Beneficial InterestSEC:0000034903-25-000008:0
18,360 shares0Common StockSEC:0000950170-24-058784:0
1,164 shares0Common Shares of Beneficial InterestSEC:0000034903-24-000009:0
10,965 shares0Common StockSEC:0001209191-23-029514:0
299 shares0Common Shares of Beneficial InterestSEC:0000034903-23-000010:0
22,857 shares0Common StockSEC:0001209191-22-046163:0
8,480 shares0Common StockSEC:0001209191-22-028911:0
20,000 shares@ US$1.0350.0% of flowCommon StockSEC:0001209191-21-051775:0
Ideal exit: 13 May 2022 (T+270)
20,000 shares@ US$1.0350.0% of flowCommon StockSEC:0001209191-21-051775
Ideal exit: 13 May 2022 (T+270)
72,254 shares0Common StockSEC:0001209191-21-044971
72,254 shares0Common StockSEC:0001209191-21-044971:0
4,885 shares0Common StockSEC:0001209191-21-032715
4,885 shares0Common StockSEC:0001209191-21-032715:0
57,803 shares0Common StockSEC:0001209191-21-031360:0
57,803 shares0Common StockSEC:0001209191-21-031360
18 of 18 declarations
About McEachin Thomas
Thomas McEachin is a Director at Pediatrix Medical Group, Inc., Surgalign Holdings, Inc., and Mednax, Inc. In this role, he participates in overseeing operations and making strategic decisions. These companies specialize in medical and healthcare services. Thomas contributes to guiding the growth and innovation strategies of all three companies.
